Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Acute trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Country / region: China Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20162
20172
20183
20194
20204
20216
202213
202312
202418
202515
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting40
Unknown status24
Not yet recruiting11
Active, not recruiting9
Completed9
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The First Affiliated Hospital of Soochow University17
First Affiliated Hospital of Zhejiang University7
Institute of Hematology & Blood Diseases Hospital, China7
Ruijin Hospital6
Chinese PLA General Hospital5
Beijing 302 Hospital4
Peking University People's Hospital4
The First Affiliated Hospital of Xiamen University4
Shanghai Jiao Tong University School of Medicine3
Children's Hospital of Soochow University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute95
Recurrence8
Myelodysplastic Syndromes7
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Leukemia3
Neoplasm, Residual2
Anemia, Refractory, with Excess of Blasts1
Leukemia, Biphenotypic, Acute1
Leukemia, Erythroblastic, Acute1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1

Trials

Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.